Apurva Prakash

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

Gina A. Montealegre Sanchez, Adam Reinhardt, Suzanne Ramsey et al. · Journal of Clinical Investigation · 2018 · 496 citations · Full text

The Clinical Importance of Changes in the 0 to 10 Numeric Rating Scale for Worst, Least, and Average Pain Intensity: Analyses of Data from Clinical Trials of Duloxetine in Pain Disorders

John T. Farrar, Yili Pritchett, Michael J. Robinson et al. · Journal of Pain · 2009 · 248 citations

Numeric Rating Scale, Pain Therapy, Pain Syndrome +10

Fluoxetine Versus Placebo in Posttraumatic Stress Disorder

Ferenc Martényi, Eileen B. Brown, Harry Zhang et al. · The Journal of Clinical Psychiatry · 2002 · 215 citations

Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder

Anita H. Clayton, Susan G. Kornstein, Apurva Prakash et al. · The Journal of Sexual Medicine · 2007 · 148 citations

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

Andrew A. Nierenberg, John H. Greist, Craig Mallinckrodt et al. · Current Medical Research and Opinion · 2007 · 132 citations